PCV (13-valent, adsorbed): patient group direction (PGD) template
- Public Health England
- Part of:
- Immunisation patient group direction (PGD) templates
- First published:
- 4 February 2016
PGD template to support the national pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV) vaccination programme.
Ref: PHE publications gateway number: 2015618 MS Word Document, 185KB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This patient group direction (PGD) template is to support the national pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV) vaccination programme for individuals from 8 weeks to under 2 years of age. It is valid from 1 February 2016 to 31 January 2018.
The PGD template requires further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs on behalf of NHS England for their geographical area. The PGD is not legal or valid without this local, formal authorisation.
Adoption and governance of the use of this PGD is the responsibility of the authorising commissioning body and providers.
Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.
Published: 4 February 2016